European Journal of Pharmaceutical Sciences, 1879-0720

Journal

More filtering options
  1. 2013
  2. Glycerol and urea can be used to increase skin permeability in reduced hydration conditions.

    Björklund, S., Engblom, J., Thuresson, K. & Emma Sparr, 2013, In : European Journal of Pharmaceutical Sciences. 50, 5, p. 638-645

    Research output: Contribution to journalReview article

  3. Mechanistic modelling of drug release from a polymer matrix using magnetic resonance microimaging.

    Kaunisto, E., Tajarobi, F., Abrahmsen-Alami, S., Larsson, A., Bernt Nilsson & Anders Axelsson, 2013, In : European Journal of Pharmaceutical Sciences. 48, 4-5, p. 698-708

    Research output: Contribution to journalArticle

  4. 2010
  5. Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model.

    Cervin, C., Tinzl, M., Johnsson, M., Abrahamsson, P-A., Tiberg, F. & Dizeyi, N., 2010, In : European Journal of Pharmaceutical Sciences. 41, p. 369-375

    Research output: Contribution to journalArticle

  6. 2009
  7. A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayers

    Cervin, C., Vandoolaeghe, P., Nistor, C., Tiberg, F. & Johnsson, M., 2009, In : European Journal of Pharmaceutical Sciences. 36, 4-5, p. 377-385

    Research output: Contribution to journalArticle

  8. 2008
  9. Gene therapy for Parkinson's disease

    Anders Björklund, 2008, In : European Journal of Pharmaceutical Sciences. 34, 1, Suppl. 1, p. S14-S14

    Research output: Contribution to journalPublished meeting abstract

  10. 2007
  11. A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: Experiences from 13 phase I studies.

    Nyberg, L., Wiking Månsson, Abrahamsson, B., Seidegard, J. & Borga, O., 2007, In : European Journal of Pharmaceutical Sciences. 30, 5, p. 432-440

    Research output: Contribution to journalArticle

  12. Morphological observations on a lipid-based drug delivery system during in vitro digestion

    Fatouros, D. G., Björn Bergenståhl & Mullertz, A., 2007, In : European Journal of Pharmaceutical Sciences. 31, 2, p. 85-94

    Research output: Contribution to journalArticle

  13. Structural characterization of insulin NPH formulations

    Norrman, M., Hubalek, F. & Schluckebier, G., 2007, In : European Journal of Pharmaceutical Sciences. 30, 5, p. 414-423

    Research output: Contribution to journalArticle

  14. The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.

    Petersen, A. H., Laursen, T., Bo Ahrén, Pieber, T. R., Clauson, P. & Per Wollmer, 2007, In : European Journal of Pharmaceutical Sciences. 30, 3-4, p. 351-357

    Research output: Contribution to journalArticle

  15. 2003
  16. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine.

    Mercke Odeberg, J., Kaufmann, P., Kroon, K. G. & Peter Höglund, 2003, In : European Journal of Pharmaceutical Sciences. 20, 4-5, p. 375-382

    Research output: Contribution to journalArticle

  17. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations.

    Mercke Odeberg, J., Lignell, A., Pettersson, A. & Peter Höglund, 2003, In : European Journal of Pharmaceutical Sciences. 19, 4, p. 299-304

    Research output: Contribution to journalArticle

  18. 2000
  19. Anti-arthritic effect of methotrexate: is it really mediated by adenosine?

    Andersson, S., Johansson, L. H., Lexmuller, K. & Ekstrom, G. M., 2000, In : European Journal of Pharmaceutical Sciences. 9, 4, p. 333-343

    Research output: Contribution to journalArticle